Projects per year
Personal profile
Education
- 1987.09-1994.06 MD, School of Medicine, Taipei Medical University
Experience
- 2024.08- Director, International Ph.D. Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University
- 2023.05- Professor, Department of Internal Medicine, School of Medicin, College of Medicine, Taipei Medical University
- 2023.05- Director, Clinical Research Center, Taipei Medical University Hospital
- 2022.06- Vice Superintendent, Taipei Cancer Center, Taipei Medical Uni versity
- 2022.06- Doctor, Taipei Medical University Hospital
- 1996.06-2022.06 Doctor, Department of Medicine, Taipei Veterans General Hospital, Taiwan
- 1994.06-1996.06 Doctor, Yuanshan Branch, Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Chao-Hua Chiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Role of the Positron Emission Tomography Imaging in the Local Management of Small Subsolid Lung Tumors – Part I
Chiu, C.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Application of Liquid Biopsy for the Improvement of Current Low-Dose Ct Lung Cancer Screening Program – Precision Medicine in Cancer Screening
Chiu, C.-H. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Chiu, C.-H. (PI)
7/15/23 → 7/14/24
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
發展新穎早期肺癌防治計畫
Chiu, C.-H. (PI)
1/1/23 → 12/31/23
Project: B - Project of TMU › h - Higher Education Sprout Project
-
抑制EGFR和VEGFR對EGFR突變非小細胞肺癌病患循環免疫微環境的影響
Chiu, C.-H. (PI)
1/1/23 → 12/31/23
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Lee, C. K., Liao, B. C., Subramaniam, S., Chiu, C. H., Mersiades, A. J., Ho, C. C., Brown, C., Lai, C. L., Hughes, B. G. M., Yang, T. Y., O'Byrne, K., Luo, Y. H., Yip, S., Ho, C. L., Bray, V., Su, W. C., Moore, M., Feng, W. L., Bai, Y. Y. & Ford, K. & 5 others, , Feb 2025, In: JTO Clinical and Research Reports. 6, 2, 100771.Research output: Contribution to journal › Article › peer-review
Open Access -
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas
Hung, Y. P., Lee, P. C., Chang, Y. H., Yang, M. H., Chiu, C. H., Chen, M. H., Lan, K. H., Lee, I. C., Hou, M. C., Chao, Y. & Huang, Y. H., Feb 2025, In: Alimentary Pharmacology and Therapeutics. 61, 3, p. 501-512 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report
Spira, A. I., Paz-Ares, L., Han, J. Y., Shih, J. Y., Mascaux, C., Roy, U. B., Zugazagoitia, J., Kim, Y. J., Chiu, C. H., Kim, S. W., Nadal, E., Gil-Bazo, I., Murphy, S. P., Anderson, B. G., Xia, Y., Wang, G., Bauml, J. M., Chioda, M., Simoes, J. & Mahadevia, P. J. & 1 others, , 2025, (Accepted/In press) In: Journal of Thoracic Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non–Small-Cell Lung Cancer
Fan, Y., Drilon, A., Chiu, C. H., Loong, H. H. F., Siena, S., Krzakowski, M., Dziadziuszko, R., Zeuner, H., Xue, C. & Krebs, M. G., Mar 2024, In: Clinical Lung Cancer. 25, 2, p. e81-e86.e4Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Challenges of lung cancer control in Asia
Chiu, C. H. & Yang, P. C., Aug 2024, In: EClinicalMedicine. 74, 102706.Research output: Contribution to journal › Comment/debate › peer-review
Open Access